MedPath

Safety and efficacy of the mesenchymal stromal cells therapy for the accelerates engraftment in the hematopoietic stem cell transplantatio

Not Applicable
Conditions
post transplantation GVHD
Registration Number
JPRN-UMIN000015164
Lead Sponsor
agoya University Graduate School of Medicine
Brief Summary

1 patient was treated with MSC without any trouble and acieved engraftment.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

The patients who have uncntrol infection, allergy for MSC, abnormal Cre and T-bil.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety of the therapy
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath